Rural-Urban Residence and Maternal Hepatitis C Infection, U.S.: 2010-2018
Overview
Affiliations
Introduction: The prevalence of hepatitis C virus infection among women delivering live births in the U.S. may be higher in rural areas where county-level estimates may be unreliable. The aim of this study is to model county-level maternal hepatitis C virus infection among deliveries in the U.S.
Methods: In 2020, U.S. natality files (2010-2018) with county-level maternal residence information were used from states that had adopted the 2003 revised U.S. birth certificate, which included a field for hepatitis C virus infection present during pregnancy. Hierarchical Bayesian spatial models with spatiotemporal random effects were applied to produce stable annual county-level estimates of maternal hepatitis C virus infection for years when all states had adopted the revised birth certificate (2016-2018). Models included a 6-Level Urban-Rural County Classification Scheme along with the birth year and county-specific covariates to improve posterior predictions.
Results: Among approximately 32 million live births, the overall prevalence of maternal hepatitis C virus infection was 3.5 per 1,000 births (increased from 2.0 in 2010 to 5.0 in 2018). During 2016-2018, posterior predicted median county-level maternal hepatitis C virus infection rates showed that nonurban counties had 3.5-3.8 times higher rates of hepatitis C virus than large central metropolitan counties. The counties in the top 10th percentile for maternal hepatitis C virus rates in 2018 were generally located in Appalachia, in Northern New England, along the northern border in the Upper Midwest, and in New Mexico.
Conclusions: Further implementation of community-level interventions that are effective in reducing maternal hepatitis C virus infection and its subsequent morbidity may help to reduce geographic and rural disparities.
Gizamba J, Finch B, Wang S, Klausner J BMC Public Health. 2025; 25(1):687.
PMID: 39972312 PMC: 11841175. DOI: 10.1186/s12889-025-21668-w.
Abbasi F, Almukhtar M, Fazlollahpour-Naghibi A, Alizadeh F, Behzad Moghadam K, Tadi M EClinicalMedicine. 2023; 66:102327.
PMID: 38045801 PMC: 10692665. DOI: 10.1016/j.eclinm.2023.102327.
Khan M, Thompson W, Osinubi A, Meyer Rd W, Kaufman H, Armstrong P JMIR Public Health Surveill. 2023; 9:e40783.
PMID: 37756048 PMC: 10568399. DOI: 10.2196/40783.
Maternal hepatitis C prevalence and trends by county, US: 2016-2020.
Ahrens K, Rossen L, Burgess A, Palmsten K, Ziller E Paediatr Perinat Epidemiol. 2022; 37(2):134-142.
PMID: 36372984 PMC: 9918643. DOI: 10.1111/ppe.12934.
Patrick S, Dupont W, McNeer E, McPheeters M, Cooper W, Aronoff D JAMA Health Forum. 2022; 2(10):e213470.
PMID: 35977167 PMC: 8727040. DOI: 10.1001/jamahealthforum.2021.3470.